
Keywords: AA-AGE, acetaldehyde-derived advanced glycation end product; ACR, acrolein; AFLD, alcoholic fatty liver disease; AGE-albumin, advanced glycation end product-albumin adduct; ALDH2, mitochondrial low-Km aldehyde dehydrogenase 2; AMPK, AMP-activated protein